Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c

array:24 ["pii" => "S1665268123001916" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101087" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "101087" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2023" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Ann Hepatol. 2023;28:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S1665268123001874" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101083" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "101083" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Ann Hepatol. 2023;28:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Hepatitis C mortality trends in Mexico from 2001 to 2017" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0001" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2222 "Ancho" => 2917 "Tamanyo" => 262214 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0002" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Total cases of mortality by non-alcoholic liver disease and proportion of attributable cases to HCV. Panel A. Other acute viral hepatitis (B17), Panel B. Chronic viral hepatitis (B18), Panel C. Other acute and chronic viral hepatitis, Panel D. Malignant neoplasm of liver and intrahepatic bile ducts (C22), Fibrosis and cirrhosis of the liver (K74), Hepatic Other inflammatory liver diseases (K75), and Chronic hepatitis (K73). The left y-axis represents the proportion of cases attributable to HCV (line), and the right y-axis, the total cases for each disease code (bars)." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María Carolina Martínez-Bohorquez, Martha Carnalla, Norberto Chávez-Tapia, Tonatiuh Barrientos-Gutiérrez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "María Carolina" "apellidos" => "Martínez-Bohorquez" ] 1 => array:2 [ "nombre" => "Martha" "apellidos" => "Carnalla" ] 2 => array:2 [ "nombre" => "Norberto" "apellidos" => "Chávez-Tapia" ] 3 => array:2 [ "nombre" => "Tonatiuh" "apellidos" => "Barrientos-Gutiérrez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123001874?idApp=UINPBA00004N" "url" => "/16652681/0000002800000003/v2_202305031521/S1665268123001874/v2_202305031521/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1665268123001886" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101084" "estado" => "S300" "fechaPublicacion" => "2023-05-01" "aid" => "101084" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Ann Hepatol. 2023;28:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortality" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0001" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1255 "Ancho" => 1667 "Tamanyo" => 97837 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Fig " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Forest plot showing adjusted odds ratios (aORs) and 95% confidence intervals for factors associated with inpatient mortality on multivariable analysis." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mahak Chauhan, Talan Zhang, Paul J. Thuluvath" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Mahak" "apellidos" => "Chauhan" ] 1 => array:2 [ "nombre" => "Talan" "apellidos" => "Zhang" ] 2 => array:2 [ "nombre" => "Paul J." "apellidos" => "Thuluvath" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123001886?idApp=UINPBA00004N" "url" => "/16652681/0000002800000003/v2_202305031521/S1665268123001886/v2_202305031521/en/main.assets" ] "asociados" => array:2 [ 0 => array:18 [ "pii" => "S166526812300217X" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101113" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "101113" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Ann Hepatol. 2023;28:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "Letters to the editor" "titulo" => "Comment on “Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Zhenjing Wang, Nai Liu, Caixia Guo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Zhenjing" "apellidos" => "Wang" ] 1 => array:2 [ "nombre" => "Nai" "apellidos" => "Liu" ] 2 => array:2 [ "nombre" => "Caixia" "apellidos" => "Guo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S166526812300217X?idApp=UINPBA00004N" "url" => "/16652681/0000002800000004/v1_202306271139/S166526812300217X/v1_202306271139/en/main.assets" ] 1 => array:18 [ "pii" => "S1665268123002181" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.101114" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "101114" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Ann Hepatol. 2023;28:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "Letters to the editor" "titulo" => "Reply to: Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:2 [ 0 => array:2 [ "autoresLista" => "Hirsh D. Trivedi" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Hirsh D." "apellidos" => "Trivedi" ] ] ] 1 => array:2 [ "autoresLista" => "Michelle Lai" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Michelle" "apellidos" => "Lai" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123002181?idApp=UINPBA00004N" "url" => "/16652681/0000002800000004/v1_202306271139/S1665268123002181/v1_202306271139/en/main.assets" ] ] "en" => array:17 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c" "tieneTextoCompleto" => true "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Hirsh D. Trivedi, Qua Tran, Zachary Fricker, Michael P. Curry, Jonathan X. Li, Michelle Lai" "autores" => array:6 [ 0 => array:4 [ "nombre" => "Hirsh D." "apellidos" => "Trivedi" "email" => array:1 [ 0 => "Hirsh.Trivedi@cshs.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0001" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0001" ] ] ] 1 => array:3 [ "nombre" => "Qua" "apellidos" => "Tran" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0003" ] ] ] 2 => array:3 [ "nombre" => "Zachary" "apellidos" => "Fricker" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0002" ] ] ] 3 => array:3 [ "nombre" => "Michael P." "apellidos" => "Curry" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0002" ] ] ] 4 => array:3 [ "nombre" => "Jonathan X." "apellidos" => "Li" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0004" ] ] ] 5 => array:3 [ "nombre" => "Michelle" "apellidos" => "Lai" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0002" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Karsh Division of Gastroenterology & Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA" "etiqueta" => "a" "identificador" => "aff0001" ] 1 => array:3 [ "entidad" => "Division of Gastroenterology & Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA" "etiqueta" => "b" "identificador" => "aff0002" ] 2 => array:3 [ "entidad" => "Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA" "etiqueta" => "c" "identificador" => "aff0003" ] 3 => array:3 [ "entidad" => "Department of Medicine, Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA" "etiqueta" => "d" "identificador" => "aff0004" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0001" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0002" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1903 "Ancho" => 1667 "Tamanyo" => 167294 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0002" "detalle" => "Fig " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "A proposed algorithm for non-alcoholic fatty liver disease screening in patients with type 2 diabetes in resource-limited settings. NAFLD: non-alcoholic fatty liver disease." ] ] ] "textoCompleto" => "1IntroductionThe incidence of non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), is rising [<a class="elsevierStyleCrossRef" href="#bib0001">1</a>,<a class="elsevierStyleCrossRef" href="#bib0002">2</a>]. Patients with advanced fibrosis or cirrhosis from NASH are at increased risk of complications, including the development of hepatocellular carcinoma (HCC) [<a class="elsevierStyleCrossRef" href="#bib0003">3</a>,<a class="elsevierStyleCrossRef" href="#bib0004">4</a>]. Additionally, NAFLD leads to poorer quality of life and significantly increases healthcare costs and resource utilization <a class="elsevierStyleCrossRefs" href="#bib0005">[5–7]</a>.NAFLD is prevalent but under-recognized in the primary care setting [<a class="elsevierStyleCrossRef" href="#bib0008">8</a>,<a class="elsevierStyleCrossRef" href="#bib0009">9</a>]. Certain high-risk populations, such as those with type 2 diabetes, are significantly more affected by NAFLD <a class="elsevierStyleCrossRef" href="#bib0010">[10]</a>, but large-scale screening strategies are challenging to implement. Patients with type 2 diabetes have an increased risk of NAFLD, advanced fibrosis, and HCC compared to those without type 2 diabetes <a class="elsevierStyleCrossRefs" href="#bib0011">[11–13]</a>. The development of NAFLD is thought to be multifactorial, of which metabolic syndrome and insulin resistance, as seen in type 2 diabetes, remain the cornerstone of its pathophysiologic mechanism <a class="elsevierStyleCrossRefs" href="#bib0014">[14–16]</a>. In fact, the American Diabetes Association (ADA) recommends evaluating NAFLD in all patients with type 2 diabetes <a class="elsevierStyleCrossRef" href="#bib0017">[17]</a>.Screening all patients with type 2 diabetes is challenging. Targeting screening protocols to those with complications from diabetes may be the way forward. We know those with elevated hemoglobin A1c (HbA1c) levels, for example, have an associated increase in liver fibrosis <a class="elsevierStyleCrossRef" href="#bib0018">[18]</a>. However, whether the presence of type 2 diabetes-related complications influences the degree of fibrosis, independent of HbA1c, is yet to be determined. More clearly defining which patients with type 2 diabetes are at higher risk of fibrosis from NAFLD can help narrow targets for screening and improve screening uptake in primary care practices.The fibrosis-4 (FIB-4) index, a non-invasive serologic test shown to predict advanced fibrosis, cirrhosis, cardiovascular events, and mortality in those with NAFLD <a class="elsevierStyleCrossRefs" href="#bib0019">[19–21]</a>, while also risk stratifying type 2 diabetes patients in the primary care setting <a class="elsevierStyleCrossRefs" href="#bib0022">[22–25]</a>. We sought to evaluate whether the presence of type 2 diabetes complications is associated with higher degrees of liver fibrosis, measured by FIB-4.2Materials and MethodsIn this cross-sectional cohort study, we collected information on all patients with type 2 diabetes from a primary care practice at Beth Israel Deaconess Medical Center (BIDMC) who had available FIB-4 score data (age, aspartate aminotransferase [AST], alanine aminotransferase [ALT], and platelet count). We collected patient demographics, laboratory variables, and clinical data from May 2019 to May 2021. Complications of type 2 diabetes were defined as a composite measure, including nephropathy, retinopathy, and neuropathy, identified by using the International Classification of Diseases (ICD)-10 coding. As previously proposed by Vallet-Pichard et al.<a class="elsevierStyleCrossRef" href="#bib0026">[26]</a>, the categorical FIB-4 score was separated into three stages: limited fibrosis (<1.45), indeterminate fibrosis (1.45-3.25), and advanced fibrosis (>3.25). We excluded patients with known liver disease from primary biliary cholangitis (N=6), viral hepatitis A and B (N=88), autoimmune hepatitis (N=8) and alcohol-associated liver disease (ALD)(N=33) identified by ICD-10 codes. Problem lists were examined to identify alcohol and tobacco history. Medications were captured from patient medication lists within the record. Institutional Review Board approval was obtained to perform this study.2.1Statistical methodsNormally distributed variables were reported as mean and standard deviation (SD) and compared using Student's T-test. Variables that were not normally distributed were reported as the median and interquartile range (IQR) and compared using the Wilcoxon ranksum test. The chi-square test was used to compare categorical variables, which were reported as percentages. We evaluated the association of type 2 diabetes complications with continuous and categorical FIB-4 score using univariable and multivariable linear and ordinal logistic regression models, respectively. To validate the FIB-4 scores with better non-invasive fibrosis metrics, using transient elastography (TE), we correlated continuous FIB-4 score with median liver stiffness measurement (LSM) scores using the Pearson correlation coefficient. An alpha level of 0.05 was used to determine statistical significance. Stata version 16.1 (StataCorp LLC, College Station, TX) was used for all analyses.2.2Ethical statementWritten informed consent was not required for the conduction of this study as it did not involve the recruitment of human subjects. However, Institutional Review Board (IRB) approval at BIDMC (2019P000886) was obtained to conduct this retrospective chart review.3ResultsOf those with type 2 diabetes (N=3855) in the BIDMC primary care database, 2389 (62%) had labs available to calculate a FIB4 score. After excluding patients with another known liver disease, 2254 subjects were included in the study. Forty-six percent of the study population had complications of type 2 diabetes (N=1026). Of these patients, 444 (20%) had retinopathy, 695 (31%) had neuropathy, and 422 (19%) had nephropathy. <a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a> demonstrates the characteristics of the study population. Those with complications from type 2 diabetes were older (68±12 vs. 63±13 years) and had higher HbA1c levels (7.9% [63 mmol/mol] vs. 7.3% [56 mmol/mol], P=0.005) compared to those without complications. However, there was no difference in the proportion of females between the two groups. However, patients with complicated type 2 diabetes had higher international normalized ratio (INR) and creatinine levels but lower low-density lipoprotein (LDL). Prescription of aspirin, statin, and insulin was more frequent among those with complications. Patients with type 2 diabetes complications had a higher median FIB-4 score (1.34 vs. 1.12, P<0.001). Once FIB-4 was categorized, those with complications had greater estimated fibrosis (low: 55% vs. 69%, indeterminate: 39% vs. 27%, advanced: 5.2% vs. 3.7% for complicated vs. uncomplicated type 2 diabetes, respectively).<elsevierMultimedia ident="tbl0001"></elsevierMultimedia>The presence of type 2 diabetes complications was associated with continuous and categorical FIB-4 scores in unadjusted and adjusted regression models (<a class="elsevierStyleCrossRef" href="#tbl0002">Table 2</a>). On adjusted analysis accounting for a priori selected covariates including body-mass index (BMI), sex, HbA1c, and alcohol use, type 2 diabetes complications were significantly associated with fibrosis by continuous FIB-4 score (Beta-coefficient 0.23, 95% confidence interval [CI]: 0.004-1.65, P=0.049) and demonstrated increased odds of fibrosis by the categorical FIB-4 (odds ratio [OR]: 4.48, 95% CI: 1.7-11.8, P=0.003). Additionally, in another model adjusting for covariates chosen through stepwise selection, type 2 diabetes complications remain significantly associated with increased odds of fibrosis by categorical FIB-4 score (OR: 3.96, 95% CI: 1.57-9.9, P=0.004).<elsevierMultimedia ident="tbl0002"></elsevierMultimedia>Of the study population, 276 (12%) patients also had LSM from TE. A Pearson correlation coefficient between continuous FIB-4 score and LSM from TE was 0.51 (P<0.0001), indicating a moderate correlation between the two metrics in this study population of those with type 2 diabetes within the primary care setting. <a class="elsevierStyleCrossRef" href="#fig0001">Fig. 1</a> graphically demonstrates the correlation of LSM with the three FIB-4 categories.<elsevierMultimedia ident="fig0001"></elsevierMultimedia>4DiscussionType 2 diabetes is an important associated factor of NAFLD and its complications [<a class="elsevierStyleCrossRef" href="#bib0011">11</a>,<a class="elsevierStyleCrossRef" href="#bib0013">13</a>], but screening strategies are suboptimal <a class="elsevierStyleCrossRef" href="#bib0008">[8]</a>. Targeted liver fibrosis evaluation for those with type 2 diabetes who are at the highest risk of NAFLD may help narrow screening strategies. In this study, we demonstrate patients with type 2 diabetes complications, namely nephropathy, retinopathy, and neuropathy, are at increased risk of hepatic fibrosis and may represent a suitable screening target in primary care settings.Optimal screening strategies for fibrosis from NAFLD in the community are under study. However, FIB-4 is an easily accessible and reliable tool comprising simple laboratory parameters, which predicts advanced fibrosis and its related complications in those with type 2 diabetes <a class="elsevierStyleCrossRef" href="#bib0022">[22]</a>. In two recent studies by Vieira Barbosa et al., an elevated FIB-4 score was independently associated with HCC, liver transplantation, cardiovascular events, and all-cause mortality [<a class="elsevierStyleCrossRef" href="#bib0019">19</a>,<a class="elsevierStyleCrossRef" href="#bib0020">20</a>]. FIB-4 can therefore be used to screen and risk stratify patients within the community who may be at risk of fibrosis from NAFLD.In this study, we demonstrate a significantly higher degree of fibrosis, measured by FIB-4, in the presence of type 2 diabetes complications. In this primary care cohort, patients with complications of type 2 diabetes had 4.5 times greater odds of fibrosis independent of HbA1c and other important covariates. When measuring the FIB-4 score as a continuous outcome, those with complications had higher degrees of fibrosis (Beta-coefficient 0.83, P=0.049). Additionally, in those who had available TE measurements, we demonstrated a significant correlation of FIB-4 scores with LSM by TE (P<0.0001), reinforcing the value of FIB-4 for the estimation of hepatic fibrosis in this population.These results suggest type 2 diabetes complications, defined by the presence of diabetic neuropathy, retinopathy, or nephropathy, are an important consideration when evaluating patients for NAFLD-related risk, particularly in resource-limited settings where more advanced diagnostic tools, such as TE or liver biopsy, may not be available and where widespread implementation of screening may be challenging. Although non-invasive assessment of fibrosis in those with type 2 diabetes is limited in accuracy <a class="elsevierStyleCrossRef" href="#bib0027">[27]</a>, the FIB-4 score reliably serves as an initial screening method to inform the need for subsequent fibrosis assessment and/or specialist referral. Validated non-invasive measures, such as the Hepamet fibrosis scoring system, are more accurate <a class="elsevierStyleCrossRef" href="#bib0028">[28]</a> but require specialized parameters (i.e., homeostatic model assessment score) not readily available in resource-limited settings. Evaluating those with type 2 diabetes complications using the FIB-4 score may help primary providers or healthcare systems identify those patients most at risk for liver-related complications from NAFLD and focus resources accordingly (e.g., sub-specialty consultation). <a class="elsevierStyleCrossRef" href="#fig0002">Fig. 2</a> illustrates a proposed algorithm for screening high-risk patients with type 2 diabetes in resource-limited settings.<elsevierMultimedia ident="fig0002"></elsevierMultimedia>Although the results are revealing, limitations of this study exist. First off, a more granular alcohol use history was not reliably captured in the record. Although those with known ALD were excluded, individuals with high-risk drinking behaviors may have been inadvertently included in the study population leading to misclassification. Additionally, patients who did not have available FIB-4 labs were not evaluated in this study, which may lead to selection bias. FIB-4 is also less reliable in those above 65 years of age and should be interpreted with caution in this subgroup or be used with different cut-off values, as suggested by McPherson et al. <a class="elsevierStyleCrossRef" href="#bib0029">[29]</a>. Additional factors, such as gamma-glutamyl transferase levels, glycemic/metabolic variability, or the presence of diabetic foot ulcer, are associated with type 2 diabetes, NAFLD, or related conditions but were not captured reliably in our record and may serve as future targets for study. Lastly, the retrospective nature of the study does not permit inquiry into the indication for laboratory testing. We adjusted for measured covariates; however, unmeasured covariates may still exist. Estimating fibrosis levels with the gold standard diagnostic method of liver biopsy is challenging when studying patients in the primary care community, but a preponderance of evidence now suggests FIB-4 as a reliable screening tool.5ConclusionsDespite these limitations, the results from this study support the use of FIB-4 as a straightforward and low-cost method for the triage of diabetic patients at greatest risk for liver-related complications. In settings where evaluation with advanced non-invasive modalities for fibrosis staging and/or hepatology consultation is not available for all patients at risk of chronic liver disease, the FIB-4 score can serve as an effective method for identifying the patients at greatest risk. In conclusion, patients with type 2 diabetes, and particularly those with complications, should have non-invasive liver fibrosis evaluation as a component of their systematic type 2 diabetes screening protocols.FundingHDT is supported by AASLD Transplant Hepatology Award. ZF is supported by the AASLD Foundation. MPC receives research funding from Sonic Incytes, Gilead, and Mallinckrodt, as well as consulting fees from Gilead, Sonic Incytes, Mallinckrodt and Alexion. This work was completed independently of the above funding sources.Declaration of interestNone.Author contributionsHirsh D. Trivedi: Conceptualization, Formal analysis, Data curation, Writing – review & editing. Qua Tran: Formal analysis, Data curation. Zachary Fricker: Writing – review & editing, Supervision, Visualization. Michael P. Curry: Supervision, Visualization. Jonathan X. Li: Conceptualization, Supervision, Visualization. Michelle Lai: Conceptualization, Supervision, Visualization." "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:2 [ "identificador" => "xpalclavsec1637471" "titulo" => "Keywords" ] 1 => array:2 [ "identificador" => "xpalclavsec1637472" "titulo" => "Abbreviations" ] 2 => array:2 [ "identificador" => "sec0001" "titulo" => "Introduction" ] 3 => array:3 [ "identificador" => "sec0002" "titulo" => "Materials and Methods" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0003" "titulo" => "Statistical methods" ] 1 => array:2 [ "identificador" => "sec0004" "titulo" => "Ethical statement" ] ] ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Results" ] 5 => array:2 [ "identificador" => "sec0006" "titulo" => "Discussion" ] 6 => array:2 [ "identificador" => "sec0007" "titulo" => "Conclusions" ] 7 => array:2 [ "identificador" => "sec0008" "titulo" => "Funding" ] 8 => array:2 [ "identificador" => "coi0001" "titulo" => "Declaration of interest" ] 9 => array:2 [ "identificador" => "sec0008a" "titulo" => "Author contributions" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2022-11-10" "fechaAceptado" => "2023-01-24" "PalabrasClave" => array:1 [ "en" => array:2 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1637471" "palabras" => array:4 [ 0 => "Nonalcoholic fatty liver disease" 1 => "Type 2 diabetes" 2 => "Hepatic steatosis" 3 => "Hepatic fibrosis" ] ] 1 => array:4 [ "clase" => "abr" "titulo" => "Abbreviations" "identificador" => "xpalclavsec1637472" "palabras" => array:21 [ 0 => "ADA" 1 => "ALD" 2 => "AST" 3 => "ALT" 4 => "BIDMC" 5 => "CI" 6 => "FIB-4" 7 => "HCC" 8 => "HbA1c" 9 => "ICD" 10 => "IRB" 11 => "INR" 12 => "IQR" 13 => "LDL" 14 => "BMI" 15 => "LSM" 16 => "NAFLD" 17 => "NASH" 18 => "P" 19 => "TE" 20 => "TX" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "Introduction and ObjectivesThe association between type 2 diabetes, non-alcoholic fatty liver disease, and liver fibrosis is well established, but it is unknown whether complications of type 2 diabetes influence fibrosis levels. We defined the complications of type 2 diabetes by the presence of diabetic nephropathy, retinopathy, or neuropathy and aimed to evaluate their association with the degree of liver fibrosis measured by the fibrosis-4 (FIB-4) index. Materials and MethodsThis is a cross-sectional study evaluating the association of type 2 diabetes complications with liver fibrosis. A total of 2389 participants were evaluated from a primary care practice. FIB-4 was evaluated as a continuous and categorical measure using linear and ordinal logistic regression. ResultsPatients with complications were older, had higher hemoglobin A1c, and a higher median FIB-4 score (1.34 vs. 1.12, P<0.001). On adjusted analysis, type 2 diabetes complications were associated with higher fibrosis by continuous FIB-4 score (Beta-coefficient: 0.23, 95% confidence interval [CI]: 0.004-1.65) and demonstrated increased odds of fibrosis by categorical FIB-4 score (odds ratio [OR]: 4.48, 95% CI: 1.7-11.8, P=0.003), independent of hemoglobin A1c level. ConclusionsThe presence of type 2 diabetes complications is associated with the degree of liver fibrosis, independent of hemoglobin A1c level." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abss0001" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abss0002" "titulo" => "Materials and Methods" ] 2 => array:2 [ "identificador" => "abss0003" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abss0004" "titulo" => "Conclusions" ] ] ] ] "multimedia" => array:4 [ 0 => array:8 [ "identificador" => "fig0001" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1211 "Ancho" => 1667 "Tamanyo" => 79678 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Fig " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Liver stiffness measurement (LSM) by transient elastography correlates with Fibrosis-4 score categories. FIB-4: fibrosis-4 score. LSM values are reported as median (interquartile range)." ] ] 1 => array:8 [ "identificador" => "fig0002" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1903 "Ancho" => 1667 "Tamanyo" => 167294 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0002" "detalle" => "Fig " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "A proposed algorithm for non-alcoholic fatty liver disease screening in patients with type 2 diabetes in resource-limited settings. NAFLD: non-alcoholic fatty liver disease." ] ] 2 => array:8 [ "identificador" => "tbl0001" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0003" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "SD: standard deviation, IQR: interquartile range, BMI: body-mass index, HbA1c: hemoglobin A1c, ALT: alanine aminotransferase, AST: aspartate aminotransferase, INR: international normalized ratio, LDL: low-density lipoprotein.(Normally distributed variables are reported as mean (SD) whereas median (IQR) is reported for variables that are not normally distributed.)" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0001"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0002"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">No Complications \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0003"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Complications \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0004"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">P-value \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0005"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Total No. \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0006"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">1228 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0007"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">1026 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0008"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0009"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Age (SD), years \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0010"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">62.7 (13) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0011"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">68 (12.3) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0012"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0013"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Female, % \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0014"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">655 (53.3) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0015"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">543 (52.9) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0016"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.84 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0017"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">BMI (SD), kg/m2 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0018"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">32.3 (7) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0019"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">32.2 (8.1) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0020"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.84 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0021"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">HbA1c (SD), % [mmol/mol] \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0022"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7.3 (1.5) [56 mmol/mol] \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0023"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7.9 (1.5) [63 mmol/mol] \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0024"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.005 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0025"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">ALT level (IQR), IU/L \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0026"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">35 (24, 47) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0027"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28.5 (19, 49) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0028"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.17 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0029"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">AST level (IQR), IU/L \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0030"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">27 (19, 34) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0031"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">27.5 (19, 38) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0032"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.61 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0033"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Platelet (IQR), K/uL \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0034"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">243 (201, 308) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0035"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">234 (176, 285) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0036"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.064 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0037"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">INR (SD) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0038"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.1 (0.22) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0039"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.2 (0.4) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0040"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.078 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0041"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">LDL (SD), mg/dL \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0042"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">95.2 (38.5) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0043"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">82.2 (32.6) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0044"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.036 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0045"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Creatinine (IQR), mg/dL \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0046"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.9 (0.7, 1.0) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0047"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 (0.8, 1.4) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0048"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0049"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Any Alcohol Use (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0050"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">35 (2.9) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0051"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">39 (3.8) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0052"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.21 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0053"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Tobacco (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0054"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">100 (8.1) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0055"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">109 (10.6) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0056"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.043 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0057"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Aspirin (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0058"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">196 (16) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0059"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">271 (26.4) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0060"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0061"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Statin (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0062"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">838 (68.2) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0063"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">800 (78) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0064"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0065"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Insulin (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0066"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">139 (11.3) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0067"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">335 (32.7) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0068"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0069"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Subspecialty Hepatology Care (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0070"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">202 (16.4) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0071"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">184 (17.9) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0072"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.35 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0073"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">FIB-4 (IQR) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0074"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.12 (0.81, 1.58) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0075"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.34 (0.97, 1.90) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0076"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0077"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">FIB4 Stage (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0078"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0079"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0080"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0081"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Limited: < 1.45 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0082"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">867 (70.6) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0083"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">584 (56.9) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0084"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0085"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Indeterminate: 1.45-3.25 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0086"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">323 (26.3) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0087"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">397 (38.7) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0088"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0089"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Advanced: > 3.25 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0090"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">38 (3.1) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0091"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">45 (4.4) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0092"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3163374.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Baseline characteristics of type 2 diabetes study population." ] ] 3 => array:8 [ "identificador" => "tbl0002" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0004" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "FIB-4: fibrosis-4 index, CI: confidence interval, HbA1c: hemoglobin A1c." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0093"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Exposure \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0094"></a><th class="td-with-role" title="\n \t\t\t\t\ttable-head\n \t\t\t\t ; entry_with_role_colgroup " colspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Unadjusted</th><a name="en0095"></a><th class="td-with-role" title="\n \t\t\t\t\ttable-head\n \t\t\t\t ; entry_with_role_colgroup " colspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Model 1<a class="elsevierStyleCrossRef" href="#tb2fn1">*</a></th><a name="en0096"></a><th class="td-with-role" title="\n \t\t\t\t\ttable-head\n \t\t\t\t ; entry_with_role_colgroup " colspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Model 2<a class="elsevierStyleCrossRef" href="#tb2fn2">†</a></th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0097"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowgroup " rowspan="6" align="left" valign="top">Type 2 Diabetes Complications</td><a name="en0098"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_colgroup " colspan="6" align="center" valign="top">Continuous FIB-4 Score</td></tr><tr title="table-row"><a name="en0100"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">β-coefficient (95% CI) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0101"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">P-value \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0102"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">β-coefficient (95% CI) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0103"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">P-value \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0104"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">β-coefficient (95% CI) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0105"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">P-value \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0107"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.23 (0.11 to 0.34) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0108"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0109"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.83 (0.004 to 1.65) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0110"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.049 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0111"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.59 (-0.23 to 1.40) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0112"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.16 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0114"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_colgroup " colspan="6" align="center" valign="top">Categorical FIB-4 Score</td></tr><tr title="table-row"><a name="en0116"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Odds Ratio (95% CI) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0117"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">P-value \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0118"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Odds Ratio (95% CI) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0119"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">P-value \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0120"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Odds Ratio (95% CI) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0121"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">P-value \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0123"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">1.79 (1.51 to 2.13) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0124"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0125"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">4.48 (1.69 to 11.84) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0126"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.003 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0127"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">3.96 (1.57 to 9.99) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0128"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.004 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3163373.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tb2fn1" "etiqueta" => "⁎" "nota" => "Model 1 adjusts for body-mass index, sex, HbA1c, and any alcohol use." ] 1 => array:3 [ "identificador" => "tb2fn2" "etiqueta" => "†" "nota" => "Model 2 adjusts for covariates identified using stepwise forward selection, which includes Aspirin use in the linear model and HbA1c in the ordinal logistic model." ] ] ] "descripcion" => array:1 [ "en" => "Association of type 2 diabetes complications with Fibrosis-4 index." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec1" "bibliografiaReferencia" => array:29 [ 0 => array:3 [ "identificador" => "bib0001" "etiqueta" => "[1]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Z. Younossi" 1 => "Q.M. Anstee" 2 => "M. Marietti" 3 => "T. Hardy" 4 => "L. Henry" 5 => "M. Eslam" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrgastro.2017.109" "Revista" => array:7 [ "tituloSerie" => "Nat Rev Gastroenterol Hepatol" "fecha" => "2018" "volumen" => "15" "numero" => "1" "paginaInicial" => "11" "paginaFinal" => "20" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28930295" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0002" "etiqueta" => "[2]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of chronic liver diseases in the USA in the past three decades" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Z.M. Younossi" 1 => "M. Stepanova" 2 => "Y. Younossi" 3 => "P. Golabi" 4 => "A. Mishra" 5 => "N. Rafiq" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gutjnl-2019-318813" "Revista" => array:7 [ "tituloSerie" => "Gut" "fecha" => "2020" "volumen" => "69" "numero" => "3" "paginaInicial" => "564" "paginaFinal" => "568" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31366455" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0003" "etiqueta" => "[3]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Z.M. Younossi" 1 => "A.B. Koenig" 2 => "D. Abdelatif" 3 => "Y. Fazel" 4 => "L. Henry" 5 => "M. Wymer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.28431" "Revista" => array:7 [ "tituloSerie" => "Hepatology (Baltimore, Md)" "fecha" => "2016" "volumen" => "64" "numero" => "1" "paginaInicial" => "73" "paginaFinal" => "84" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26707365" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0004" "etiqueta" => "[4]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatocellular carcinoma in the absence of cirrhosis in united states veterans is associated with non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Mittal" 1 => "H.B. El-Serag" 2 => "Y.H. Sada" 3 => "F. Kanwal" 4 => "Z. Duan" 5 => "S. Temple" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2015.07.019" "Revista" => array:6 [ "tituloSerie" => "Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc" "fecha" => "2016" "volumen" => "14" "numero" => "1" "paginaInicial" => "124" "paginaFinal" => "131" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0005" "etiqueta" => "[5]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Severe hepatic steatosis by controlled attenuation parameter predicts quality of life independent of fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "H.D. Trivedi" 1 => "S. Niezen" 2 => "Z.G. Jiang" 3 => "E.B. Tapper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10620-021-07228-3" "Revista" => array:2 [ "tituloSerie" => "Dig Dis Sci" "fecha" => "2021" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0006" "etiqueta" => "[6]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Golabi" 1 => "M. Otgonsuren" 2 => "R. Cable" 3 => "S. Felix" 4 => "A. Koenig" 5 => "M. Sayiner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12955-016-0420-z" "Revista" => array:5 [ "tituloSerie" => "Health Qual Life Outcomes" "fecha" => "2016" "volumen" => "14" "paginaInicial" => "18" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26860700" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0007" "etiqueta" => "[7]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Healthcare cost and utilization in non-alcoholic fatty liver disease: real-world data from a large U.S. claims database" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.M. Allen" 1 => "H.K. Van Houten" 2 => "L.R. Sangaralingham" 3 => "J.A. Talwalkar" 4 => "RG. McCoy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.30094" "Revista" => array:7 [ "tituloSerie" => "Hepatology (Baltimore, Md)" "fecha" => "2018" "volumen" => "68" "numero" => "6" "paginaInicial" => "2230" "paginaFinal" => "2238" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29774589" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0008" "etiqueta" => "[8]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-alcoholic fatty liver disease is underrecognized in the primary care setting" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Blais" 1 => "N. Husain" 2 => "J.R. Kramer" 3 => "M. Kowalkowski" 4 => "H. El-Serag" 5 => "F. Kanwal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajg.2014.134" "Revista" => array:7 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2015" "volumen" => "110" "numero" => "1" "paginaInicial" => "10" "paginaFinal" => "14" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24890441" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0009" "etiqueta" => "[9]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of non-alcoholic fatty liver disease in primary care: a population health perspective" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Dokmak" 1 => "B. Lizaola-Mayo" 2 => "H.D. Trivedi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2020.08.010" "Revista" => array:2 [ "tituloSerie" => "Am J Med" "fecha" => "2020" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0010" "etiqueta" => "[10]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serial transient elastography examinations to monitor patients with type 2 diabetes: a prospective cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H.W. Lee" 1 => "G.L. Wong" 2 => "R. Kwok" 3 => "K.C. Choi" 4 => "C.K. Chan" 5 => "S.S. Shu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.31142" "Revista" => array:2 [ "tituloSerie" => "Hepatology (Baltimore, Md)" "fecha" => "2020" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0011" "etiqueta" => "[11]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Alexander" 1 => "A.K. Loomis" 2 => "J. van der Lei" 3 => "T. Duarte-Salles" 4 => "D. Prieto-Alhambra" 5 => "D. Ansell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12916-019-1321-x" "Revista" => array:6 [ "tituloSerie" => "BMC Med" "fecha" => "2019" "volumen" => "17" "numero" => "1" "paginaInicial" => "95" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31104631" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0012" "etiqueta" => "[12]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes is associated with increased risk of hepatocellular carcinoma in cirrhosis patients with non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.D. Yang" 1 => "F. Ahmed" 2 => "K.C. Mara" 3 => "B.D. Addissie" 4 => "A.M. Allen" 5 => "G.J. Gores" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.30858" "Revista" => array:2 [ "tituloSerie" => "Hepatology (Baltimore, Md)" "fecha" => "2019" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0013" "etiqueta" => "[13]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H.D. Trivedi" 1 => "J. Suri" 2 => "D. Oh" 3 => "J. Schwartz" 4 => "D. Goyes" 5 => "R. Idriss" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.aohep.2021.100336" "Revista" => array:3 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2021" "volumen" => "24" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0014" "etiqueta" => "[14]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Shedding light on non-alcoholic fatty liver disease: pathogenesis, molecular mechanisms, models, and emerging therapeutics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Khairnar" 1 => "M.A. Islam" 2 => "J. Fleishman" 3 => "S. Kumar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.lfs.2022.121185" "Revista" => array:3 [ "tituloSerie" => "Life Sci" "fecha" => "2023" "volumen" => "312" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0015" "etiqueta" => "[15]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differential associations of circulating microRNAs with pathogenic factors in NAFLD" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Ezaz" 1 => "H.D. Trivedi" 2 => "M.A. Connelly" 3 => "C. Filozof" 4 => "K. Howard" 5 => "M. LP" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep4.1501" "Revista" => array:7 [ "tituloSerie" => "Hepatol Commun" "fecha" => "2020" "volumen" => "4" "numero" => "5" "paginaInicial" => "670" "paginaFinal" => "680" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32363318" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0016" "etiqueta" => "[16]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glycemic variability is an independent predictive factor for development of hepatic fibrosis in non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Hashiba" 1 => "M. Ono" 2 => "H. Hyogo" 3 => "Y. Ikeda" 4 => "K. Masuda" 5 => "R. Yoshioka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0076161" "Revista" => array:6 [ "tituloSerie" => "PLOS One" "fecha" => "2013" "volumen" => "8" "numero" => "11" "paginaInicial" => "e76161" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24223115" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0017" "etiqueta" => "[17]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Improving care and promoting health in populations: standards of medical care in diabetes-2020" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Association AD. 1" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc20-S001" "Revista" => array:7 [ "tituloSerie" => "Diabetes Care" "fecha" => "2020" "volumen" => "43" "numero" => "Suppl 1" "paginaInicial" => "S7" "paginaFinal" => "s13" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31862744" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0018" "etiqueta" => "[18]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elevated glycated hemoglobin is associated with liver fibrosis, as assessed by elastography, in a population-based study of Mexican Americans" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.P. Watt" 1 => "I. De La Cerda" 2 => "J.J. Pan" 3 => "M.B. Fallon" 4 => "L. Beretta" 5 => "R. Loomba" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep4.1603" "Revista" => array:7 [ "tituloSerie" => "Hepatol Commun" "fecha" => "2020" "volumen" => "4" "numero" => "12" "paginaInicial" => "1793" "paginaFinal" => "1801" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33305150" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0019" "etiqueta" => "[19]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrosis-4 index as an independent predictor of mortality and liver-related outcomes in NAFLD" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Vieira Barbosa" 1 => "S. Milligan" 2 => "A. Frick" 3 => "J. Broestl" 4 => "Z. Younossi" 5 => "N.H. Afdhal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep4.1841" "Revista" => array:2 [ "tituloSerie" => "Hepatol Commun" "fecha" => "2021" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0020" "etiqueta" => "[20]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrosis-4 index can independently predict major adverse cardiovascular events in nonalcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Vieira Barbosa" 1 => "S. Milligan" 2 => "A. Frick" 3 => "J. Broestl" 4 => "Z. Younossi" 5 => "N. Afdhal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14309/ajg.0000000000001606" "Revista" => array:2 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2022" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0021" "etiqueta" => "[21]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Accuracy of non-invasive scoring systems in assessing liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Han" 1 => "M. Choi" 2 => "B. Lee" 3 => "H.W. Lee" 4 => "S.H. Kang" 5 => "Y. Cho" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5009/gnl210391" "Revista" => array:2 [ "tituloSerie" => "Gut Liver" "fecha" => "2022" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0022" "etiqueta" => "[22]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F.E. Mózes" 1 => "J.A. Lee" 2 => "E.A. Selvaraj" 3 => "A.N.A. Jayaswal" 4 => "M. Trauner" 5 => "J. Boursier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gutjnl-2021-324243" "Revista" => array:2 [ "tituloSerie" => "Gut" "fecha" => "2021" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0023" "etiqueta" => "[23]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of implementing a “FIB-4 first” strategy on a pathway for patients with NAFLD referred from primary care" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T. Davyduke" 1 => "P. Tandon" 2 => "M. Al-Karaghouli" 3 => "J.G. Abraldes" 4 => "MM. Ma" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep4.1411" "Revista" => array:7 [ "tituloSerie" => "Hepatol Commun" "fecha" => "2019" "volumen" => "3" "numero" => "10" "paginaInicial" => "1322" "paginaFinal" => "1333" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31592044" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0024" "etiqueta" => "[24]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Srivastava" 1 => "R. Gailer" 2 => "S. Tanwar" 3 => "P. Trembling" 4 => "J. Parkes" 5 => "A. Rodger" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2019.03.033" "Revista" => array:7 [ "tituloSerie" => "J Hepatol" "fecha" => "2019" "volumen" => "71" "numero" => "2" "paginaInicial" => "371" "paginaFinal" => "378" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30965069" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0025" "etiqueta" => "[25]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An algorithmic approach to NAFLD screening: from PCP to specialist" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H.D. Trivedi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14309/crj.0000000000000473" "Revista" => array:6 [ "tituloSerie" => "ACG Case Rep J" "fecha" => "2020" "volumen" => "7" "numero" => "11" "paginaInicial" => "e00473" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33195729" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0026" "etiqueta" => "[26]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Vallet-Pichard" 1 => "V. Mallet" 2 => "B. Nalpas" 3 => "V. Verkarre" 4 => "A. Nalpas" 5 => "V. Dhalluin-Venier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.21669" "Revista" => array:7 [ "tituloSerie" => "Hepatology (Baltimore, Md)" "fecha" => "2007" "volumen" => "46" "numero" => "1" "paginaInicial" => "32" "paginaFinal" => "36" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17567829" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0027" "etiqueta" => "[27]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of type 2 diabetes on the accuracy of noninvasive tests of liver fibrosis with resulting clinical implications" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Boursier" 1 => "C.M. Canivet" 2 => "C. Costentin" 3 => "A. Lannes" 4 => "A. Delamarre" 5 => "N. Sturm" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2022.02.059" "Revista" => array:2 [ "tituloSerie" => "Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc" "fecha" => "2022" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0028" "etiqueta" => "[28]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development and validation of hepamet fibrosis scoring system-a simple, noninvasive test to identify patients with non-alcoholic fatty liver disease with advanced fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Ampuero" 1 => "R. Pais" 2 => "R. Aller" 3 => "R. Gallego-Durán" 4 => "J. Crespo" 5 => "C. García-Monzón" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2019.05.051" "Revista" => array:6 [ "tituloSerie" => "Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc" "fecha" => "2020" "volumen" => "18" "numero" => "1" "paginaInicial" => "216" "paginaFinal" => "225" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0029" "etiqueta" => "[29]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. McPherson" 1 => "T. Hardy" 2 => "J.F. Dufour" 3 => "S. Petta" 4 => "M. Romero-Gomez" 5 => "M. Allison" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajg.2016.453" "Revista" => array:7 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2017" "volumen" => "112" "numero" => "5" "paginaInicial" => "740" "paginaFinal" => "751" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27725647" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000002800000003/v2_202305031521/S1665268123001916/v2_202305031521/en/main.assets" "Apartado" => array:4 [ "identificador" => "78265" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000002800000003/v2_202305031521/S1665268123001916/v2_202305031521/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123001916?idApp=UINPBA00004N"]

Statistics

Original article

Hirsh D. Trivedia,

Corresponding author

Hirsh.Trivedi@cshs.org

Corresponding author.

, Qua Tranc, Zachary Frickerb, Michael P. Curryb, Jonathan X. Lid, Michelle Laib

a Karsh Division of Gastroenterology & Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA

b Division of Gastroenterology & Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

c Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA

d Department of Medicine, Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA

Read

779

Times
was read the article

152

Total PDF

627

Total HTML

Share statistics

 array:24 [
  "pii" => "S1665268123001916"
  "issn" => "16652681"
  "doi" => "10.1016/j.aohep.2023.101087"
  "estado" => "S300"
  "fechaPublicacion" => "2023-05-01"
  "aid" => "101087"
  "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
  "copyrightAnyo" => "2023"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Ann Hepatol. 2023;28:"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1665268123001874"
    "issn" => "16652681"
    "doi" => "10.1016/j.aohep.2023.101083"
    "estado" => "S300"
    "fechaPublicacion" => "2023-05-01"
    "aid" => "101083"
    "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Ann Hepatol. 2023;28:"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Hepatitis C mortality trends in Mexico from 2001 to 2017"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0001"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 2222
              "Ancho" => 2917
              "Tamanyo" => 262214
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "alt0002"
              "detalle" => "Figure "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Total cases of mortality by non-alcoholic liver disease and proportion of attributable cases to HCV&#46;</span> Panel A&#46; Other acute viral hepatitis &#40;B17&#41;&#44; Panel B&#46; Chronic viral hepatitis &#40;B18&#41;&#44; Panel C&#46; Other acute and chronic viral hepatitis&#44; Panel D&#46; Malignant neoplasm of liver and intrahepatic bile ducts &#40;C22&#41;&#44; Fibrosis and cirrhosis of the liver &#40;K74&#41;&#44; Hepatic Other inflammatory liver diseases &#40;K75&#41;&#44; and Chronic hepatitis &#40;K73&#41;&#46; The left y-axis represents the proportion of cases attributable to HCV &#40;line&#41;&#44; and the right y-axis&#44; the total cases for each disease code &#40;bars&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Mar&#237;a Carolina Mart&#237;nez-Bohorquez, Martha Carnalla, Norberto Ch&#225;vez-Tapia, Tonatiuh Barrientos-Guti&#233;rrez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Mar&#237;a Carolina"
              "apellidos" => "Mart&#237;nez-Bohorquez"
            ]
            1 => array:2 [
              "nombre" => "Martha"
              "apellidos" => "Carnalla"
            ]
            2 => array:2 [
              "nombre" => "Norberto"
              "apellidos" => "Ch&#225;vez-Tapia"
            ]
            3 => array:2 [
              "nombre" => "Tonatiuh"
              "apellidos" => "Barrientos-Guti&#233;rrez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123001874?idApp=UINPBA00004N"
    "url" => "/16652681/0000002800000003/v2_202305031521/S1665268123001874/v2_202305031521/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1665268123001886"
    "issn" => "16652681"
    "doi" => "10.1016/j.aohep.2023.101084"
    "estado" => "S300"
    "fechaPublicacion" => "2023-05-01"
    "aid" => "101084"
    "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Ann Hepatol. 2023;28:"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortality"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig0001"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1255
              "Ancho" => 1667
              "Tamanyo" => 97837
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "alt0001"
              "detalle" => "Fig "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing adjusted odds ratios &#40;aORs&#41; and 95&#37; confidence intervals for factors associated with inpatient mortality on multivariable analysis&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Mahak Chauhan, Talan Zhang, Paul J&#46; Thuluvath"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Mahak"
              "apellidos" => "Chauhan"
            ]
            1 => array:2 [
              "nombre" => "Talan"
              "apellidos" => "Zhang"
            ]
            2 => array:2 [
              "nombre" => "Paul J&#46;"
              "apellidos" => "Thuluvath"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123001886?idApp=UINPBA00004N"
    "url" => "/16652681/0000002800000003/v2_202305031521/S1665268123001886/v2_202305031521/en/main.assets"
  ]
  "asociados" => array:2 [
    0 => array:18 [
      "pii" => "S166526812300217X"
      "issn" => "16652681"
      "doi" => "10.1016/j.aohep.2023.101113"
      "estado" => "S300"
      "fechaPublicacion" => "2023-07-01"
      "aid" => "101113"
      "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Ann Hepatol. 2023;28:"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:8 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>"
        "titulo" => "Comment on &#8220;Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c&#8221;"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Zhenjing Wang, Nai Liu, Caixia Guo"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Zhenjing"
                "apellidos" => "Wang"
              ]
              1 => array:2 [
                "nombre" => "Nai"
                "apellidos" => "Liu"
              ]
              2 => array:2 [
                "nombre" => "Caixia"
                "apellidos" => "Guo"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S166526812300217X?idApp=UINPBA00004N"
      "url" => "/16652681/0000002800000004/v1_202306271139/S166526812300217X/v1_202306271139/en/main.assets"
    ]
    1 => array:18 [
      "pii" => "S1665268123002181"
      "issn" => "16652681"
      "doi" => "10.1016/j.aohep.2023.101114"
      "estado" => "S300"
      "fechaPublicacion" => "2023-07-01"
      "aid" => "101114"
      "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Ann Hepatol. 2023;28:"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:8 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>"
        "titulo" => "Reply to&#58; Type 2 Diabetes Complications are Associated with Liver Fibrosis Independent of Hemoglobin A1c"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:2 [
          0 => array:2 [
            "autoresLista" => "Hirsh D&#46; Trivedi"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "Hirsh D&#46;"
                "apellidos" => "Trivedi"
              ]
            ]
          ]
          1 => array:2 [
            "autoresLista" => "Michelle Lai"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "Michelle"
                "apellidos" => "Lai"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123002181?idApp=UINPBA00004N"
      "url" => "/16652681/0000002800000004/v1_202306271139/S1665268123002181/v1_202306271139/en/main.assets"
    ]
  ]
  "en" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
    "titulo" => "Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c"
    "tieneTextoCompleto" => true
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Hirsh D&#46; Trivedi, Qua Tran, Zachary Fricker, Michael P&#46; Curry, Jonathan X&#46; Li, Michelle Lai"
        "autores" => array:6 [
          0 => array:4 [
            "nombre" => "Hirsh D&#46;"
            "apellidos" => "Trivedi"
            "email" => array:1 [
              0 => "Hirsh.Trivedi@cshs.org"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0001"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0001"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Qua"
            "apellidos" => "Tran"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0003"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Zachary"
            "apellidos" => "Fricker"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0002"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Michael P&#46;"
            "apellidos" => "Curry"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0002"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Jonathan X&#46;"
            "apellidos" => "Li"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0004"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Michelle"
            "apellidos" => "Lai"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0002"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:4 [
          0 => array:3 [
            "entidad" => "Karsh Division of Gastroenterology &#38; Hepatology&#44; Cedars-Sinai Medical Center&#44; Los Angeles&#44; CA&#44; USA"
            "etiqueta" => "a"
            "identificador" => "aff0001"
          ]
          1 => array:3 [
            "entidad" => "Division of Gastroenterology &#38; Hepatology&#44; Beth Israel Deaconess Medical Center&#44; Harvard Medical School&#44; Boston&#44; MA&#44; USA"
            "etiqueta" => "b"
            "identificador" => "aff0002"
          ]
          2 => array:3 [
            "entidad" => "Department of Pharmacy&#44; Beth Israel Deaconess Medical Center&#44; Boston&#44; MA&#44; USA"
            "etiqueta" => "c"
            "identificador" => "aff0003"
          ]
          3 => array:3 [
            "entidad" => "Department of Medicine&#44; Division of General Medicine&#44; Beth Israel Deaconess Medical Center&#44; Boston&#44; MA&#44; USA"
            "etiqueta" => "d"
            "identificador" => "aff0004"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0001"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0002"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1903
            "Ancho" => 1667
            "Tamanyo" => 167294
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0002"
            "detalle" => "Fig "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara002" class="elsevierStyleSimplePara elsevierViewall">A proposed algorithm for non-alcoholic fatty liver disease screening in patients with type 2 diabetes in resource-limited settings&#46; NAFLD&#58; non-alcoholic fatty liver disease&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">1</span><span class="elsevierStyleSectionTitle" id="cesectitle0007">Introduction</span><p id="para0005" class="elsevierStylePara elsevierViewall">The incidence of non-alcoholic fatty liver disease &#40;NAFLD&#41; and its more severe form&#44; non-alcoholic steatohepatitis &#40;NASH&#41;&#44; is rising &#91;<a class="elsevierStyleCrossRef" href="#bib0001">1</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0002">2</a>&#93;&#46; Patients with advanced fibrosis or cirrhosis from NASH are at increased risk of complications&#44; including the development of hepatocellular carcinoma &#40;HCC&#41; &#91;<a class="elsevierStyleCrossRef" href="#bib0003">3</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0004">4</a>&#93;&#46; Additionally&#44; NAFLD leads to poorer quality of life and significantly increases healthcare costs and resource utilization <a class="elsevierStyleCrossRefs" href="#bib0005">&#91;5&#8211;7&#93;</a>&#46;</p><p id="para0006" class="elsevierStylePara elsevierViewall">NAFLD is prevalent but under-recognized in the primary care setting &#91;<a class="elsevierStyleCrossRef" href="#bib0008">8</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0009">9</a>&#93;&#46; Certain high-risk populations&#44; such as those with type 2 diabetes&#44; are significantly more affected by NAFLD <a class="elsevierStyleCrossRef" href="#bib0010">&#91;10&#93;</a>&#44; but large-scale screening strategies are challenging to implement&#46; Patients with type 2 diabetes have an increased risk of NAFLD&#44; advanced fibrosis&#44; and HCC compared to those without type 2 diabetes <a class="elsevierStyleCrossRefs" href="#bib0011">&#91;11&#8211;13&#93;</a>&#46; The development of NAFLD is thought to be multifactorial&#44; of which metabolic syndrome and insulin resistance&#44; as seen in type 2 diabetes&#44; remain the cornerstone of its pathophysiologic mechanism <a class="elsevierStyleCrossRefs" href="#bib0014">&#91;14&#8211;16&#93;</a>&#46; In fact&#44; the American Diabetes Association &#40;ADA&#41; recommends evaluating NAFLD in all patients with type 2 diabetes <a class="elsevierStyleCrossRef" href="#bib0017">&#91;17&#93;</a>&#46;</p><p id="para0007" class="elsevierStylePara elsevierViewall">Screening all patients with type 2 diabetes is challenging&#46; Targeting screening protocols to those with complications from diabetes may be the way forward&#46; We know those with elevated hemoglobin A1c &#40;HbA1c&#41; levels&#44; for example&#44; have an associated increase in liver fibrosis <a class="elsevierStyleCrossRef" href="#bib0018">&#91;18&#93;</a>&#46; However&#44; whether the presence of type 2 diabetes-related complications influences the degree of fibrosis&#44; independent of HbA1c&#44; is yet to be determined&#46; More clearly defining which patients with type 2 diabetes are at higher risk of fibrosis from NAFLD can help narrow targets for screening and improve screening uptake in primary care practices&#46;</p><p id="para0008" class="elsevierStylePara elsevierViewall">The fibrosis-4 &#40;FIB-4&#41; index&#44; a non-invasive serologic test shown to predict advanced fibrosis&#44; cirrhosis&#44; cardiovascular events&#44; and mortality in those with NAFLD <a class="elsevierStyleCrossRefs" href="#bib0019">&#91;19&#8211;21&#93;</a>&#44; while also risk stratifying type 2 diabetes patients in the primary care setting <a class="elsevierStyleCrossRefs" href="#bib0022">&#91;22&#8211;25&#93;</a>&#46; We sought to evaluate whether the presence of type 2 diabetes complications is associated with higher degrees of liver fibrosis&#44; measured by FIB-4&#46;</p></span><span id="sec0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2</span><span class="elsevierStyleSectionTitle" id="cesectitle0008">Materials and Methods</span><p id="para0009" class="elsevierStylePara elsevierViewall">In this cross-sectional cohort study&#44; we collected information on all patients with type 2 diabetes from a primary care practice at Beth Israel Deaconess Medical Center &#40;BIDMC&#41; who had available FIB-4 score data &#40;age&#44; aspartate aminotransferase &#91;AST&#93;&#44; alanine aminotransferase &#91;ALT&#93;&#44; and platelet count&#41;&#46; We collected patient demographics&#44; laboratory variables&#44; and clinical data from May 2019 to May 2021&#46; Complications of type 2 diabetes were defined as a composite measure&#44; including nephropathy&#44; retinopathy&#44; and neuropathy&#44; identified by using the International Classification of Diseases &#40;ICD&#41;-10 coding&#46; As previously proposed by Vallet-Pichard <span class="elsevierStyleItalic">et al&#46;</span><a class="elsevierStyleCrossRef" href="#bib0026">&#91;26&#93;</a>&#44; the categorical FIB-4 score was separated into three stages&#58; limited fibrosis &#40;&#60;1&#46;45&#41;&#44; indeterminate fibrosis &#40;1&#46;45-3&#46;25&#41;&#44; and advanced fibrosis &#40;&#62;3&#46;25&#41;&#46; We excluded patients with known liver disease from primary biliary cholangitis &#40;N&#61;6&#41;&#44; viral hepatitis A and B &#40;N&#61;88&#41;&#44; autoimmune hepatitis &#40;N&#61;8&#41; and alcohol-associated liver disease &#40;ALD&#41;&#40;N&#61;33&#41; identified by ICD-10 codes&#46; Problem lists were examined to identify alcohol and tobacco history&#46; Medications were captured from patient medication lists within the record&#46; Institutional Review Board approval was obtained to perform this study&#46;</p><span id="sec0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;1</span><span class="elsevierStyleSectionTitle" id="cesectitle0009">Statistical methods</span><p id="para0010" class="elsevierStylePara elsevierViewall">Normally distributed variables were reported as mean and standard deviation &#40;SD&#41; and compared using Student&#39;s T-test&#46; Variables that were not normally distributed were reported as the median and interquartile range &#40;IQR&#41; and compared using the Wilcoxon ranksum test&#46; The chi-square test was used to compare categorical variables&#44; which were reported as percentages&#46; We evaluated the association of type 2 diabetes complications with continuous and categorical FIB-4 score using univariable and multivariable linear and ordinal logistic regression models&#44; respectively&#46; To validate the FIB-4 scores with better non-invasive fibrosis metrics&#44; using transient elastography &#40;TE&#41;&#44; we correlated continuous FIB-4 score with median liver stiffness measurement &#40;LSM&#41; scores using the Pearson correlation coefficient&#46; An alpha level of 0&#46;05 was used to determine statistical significance&#46; Stata version 16&#46;1 &#40;StataCorp LLC&#44; College Station&#44; TX&#41; was used for all analyses&#46;</p></span><span id="sec0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2&#46;2</span><span class="elsevierStyleSectionTitle" id="cesectitle0010">Ethical statement</span><p id="para0011" class="elsevierStylePara elsevierViewall">Written informed consent was not required for the conduction of this study as it did not involve the recruitment of human subjects&#46; However&#44; Institutional Review Board &#40;IRB&#41; approval at BIDMC &#40;2019P000886&#41; was obtained to conduct this retrospective chart review&#46;</p></span></span><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3</span><span class="elsevierStyleSectionTitle" id="cesectitle0011">Results</span><p id="para0012" class="elsevierStylePara elsevierViewall">Of those with type 2 diabetes &#40;N&#61;3855&#41; in the BIDMC primary care database&#44; 2389 &#40;62&#37;&#41; had labs available to calculate a FIB4 score&#46; After excluding patients with another known liver disease&#44; 2254 subjects were included in the study&#46; Forty-six percent of the study population had complications of type 2 diabetes &#40;N&#61;1026&#41;&#46; Of these patients&#44; 444 &#40;20&#37;&#41; had retinopathy&#44; 695 &#40;31&#37;&#41; had neuropathy&#44; and 422 &#40;19&#37;&#41; had nephropathy&#46; <a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a> demonstrates the characteristics of the study population&#46; Those with complications from type 2 diabetes were older &#40;68&#177;12 vs&#46; 63&#177;13 years&#41; and had higher HbA1c levels &#40;7&#46;9&#37; &#91;63&#160;mmol&#47;mol&#93; vs&#46; 7&#46;3&#37; &#91;56&#160;mmol&#47;mol&#93;&#44; P&#61;0&#46;005&#41; compared to those without complications&#46; However&#44; there was no difference in the proportion of females between the two groups&#46; However&#44; patients with complicated type 2 diabetes had higher international normalized ratio &#40;INR&#41; and creatinine levels but lower low-density lipoprotein &#40;LDL&#41;&#46; Prescription of aspirin&#44; statin&#44; and insulin was more frequent among those with complications&#46; Patients with type 2 diabetes complications had a higher median FIB-4 score &#40;1&#46;34 vs&#46; 1&#46;12&#44; P&#60;0&#46;001&#41;&#46; Once FIB-4 was categorized&#44; those with complications had greater estimated fibrosis &#40;low&#58; 55&#37; vs&#46; 69&#37;&#44; indeterminate&#58; 39&#37; vs&#46; 27&#37;&#44; advanced&#58; 5&#46;2&#37; vs&#46; 3&#46;7&#37; for complicated vs&#46; uncomplicated type 2 diabetes&#44; respectively&#41;&#46;</p><elsevierMultimedia ident="tbl0001"></elsevierMultimedia><p id="para0013" class="elsevierStylePara elsevierViewall">The presence of type 2 diabetes complications was associated with continuous and categorical FIB-4 scores in unadjusted and adjusted regression models &#40;<a class="elsevierStyleCrossRef" href="#tbl0002">Table 2</a>&#41;&#46; On adjusted analysis accounting for a priori selected covariates including body-mass index &#40;BMI&#41;&#44; sex&#44; HbA1c&#44; and alcohol use&#44; type 2 diabetes complications were significantly associated with fibrosis by continuous FIB-4 score &#40;Beta-coefficient 0&#46;23&#44; 95&#37; confidence interval &#91;CI&#93;&#58; 0&#46;004-1&#46;65&#44; P&#61;0&#46;049&#41; and demonstrated increased odds of fibrosis by the categorical FIB-4 &#40;odds ratio &#91;OR&#93;&#58; 4&#46;48&#44; 95&#37; CI&#58; 1&#46;7-11&#46;8&#44; P&#61;0&#46;003&#41;&#46; Additionally&#44; in another model adjusting for covariates chosen through stepwise selection&#44; type 2 diabetes complications remain significantly associated with increased odds of fibrosis by categorical FIB-4 score &#40;OR&#58; 3&#46;96&#44; 95&#37; CI&#58; 1&#46;57-9&#46;9&#44; P&#61;0&#46;004&#41;&#46;</p><elsevierMultimedia ident="tbl0002"></elsevierMultimedia><p id="para0014" class="elsevierStylePara elsevierViewall">Of the study population&#44; 276 &#40;12&#37;&#41; patients also had LSM from TE&#46; A Pearson correlation coefficient between continuous FIB-4 score and LSM from TE was 0&#46;51 &#40;P&#60;0&#46;0001&#41;&#44; indicating a moderate correlation between the two metrics in this study population of those with type 2 diabetes within the primary care setting&#46; <a class="elsevierStyleCrossRef" href="#fig0001">Fig&#46; 1</a> graphically demonstrates the correlation of LSM with the three FIB-4 categories&#46;</p><elsevierMultimedia ident="fig0001"></elsevierMultimedia></span><span id="sec0006" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">4</span><span class="elsevierStyleSectionTitle" id="cesectitle0012">Discussion</span><p id="para0015" class="elsevierStylePara elsevierViewall">Type 2 diabetes is an important associated factor of NAFLD and its complications &#91;<a class="elsevierStyleCrossRef" href="#bib0011">11</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0013">13</a>&#93;&#44; but screening strategies are suboptimal <a class="elsevierStyleCrossRef" href="#bib0008">&#91;8&#93;</a>&#46; Targeted liver fibrosis evaluation for those with type 2 diabetes who are at the highest risk of NAFLD may help narrow screening strategies&#46; In this study&#44; we demonstrate patients with type 2 diabetes complications&#44; namely nephropathy&#44; retinopathy&#44; and neuropathy&#44; are at increased risk of hepatic fibrosis and may represent a suitable screening target in primary care settings&#46;</p><p id="para0016" class="elsevierStylePara elsevierViewall">Optimal screening strategies for fibrosis from NAFLD in the community are under study&#46; However&#44; FIB-4 is an easily accessible and reliable tool comprising simple laboratory parameters&#44; which predicts advanced fibrosis and its related complications in those with type 2 diabetes <a class="elsevierStyleCrossRef" href="#bib0022">&#91;22&#93;</a>&#46; In two recent studies by Vieira Barbosa <span class="elsevierStyleItalic">et al</span>&#46;&#44; an elevated FIB-4 score was independently associated with HCC&#44; liver transplantation&#44; cardiovascular events&#44; and all-cause mortality &#91;<a class="elsevierStyleCrossRef" href="#bib0019">19</a>&#44;<a class="elsevierStyleCrossRef" href="#bib0020">20</a>&#93;&#46; FIB-4 can therefore be used to screen and risk stratify patients within the community who may be at risk of fibrosis from NAFLD&#46;</p><p id="para0017" class="elsevierStylePara elsevierViewall">In this study&#44; we demonstrate a significantly higher degree of fibrosis&#44; measured by FIB-4&#44; in the presence of type 2 diabetes complications&#46; In this primary care cohort&#44; patients with complications of type 2 diabetes had 4&#46;5 times greater odds of fibrosis independent of HbA1c and other important covariates&#46; When measuring the FIB-4 score as a continuous outcome&#44; those with complications had higher degrees of fibrosis &#40;Beta-coefficient 0&#46;83&#44; P&#61;0&#46;049&#41;&#46; Additionally&#44; in those who had available TE measurements&#44; we demonstrated a significant correlation of FIB-4 scores with LSM by TE &#40;P&#60;0&#46;0001&#41;&#44; reinforcing the value of FIB-4 for the estimation of hepatic fibrosis in this population&#46;</p><p id="para0018" class="elsevierStylePara elsevierViewall">These results suggest type 2 diabetes complications&#44; defined by the presence of diabetic neuropathy&#44; retinopathy&#44; or nephropathy&#44; are an important consideration when evaluating patients for NAFLD-related risk&#44; particularly in resource-limited settings where more advanced diagnostic tools&#44; such as TE or liver biopsy&#44; may not be available and where widespread implementation of screening may be challenging&#46; Although non-invasive assessment of fibrosis in those with type 2 diabetes is limited in accuracy <a class="elsevierStyleCrossRef" href="#bib0027">&#91;27&#93;</a>&#44; the FIB-4 score reliably serves as an initial screening method to inform the need for subsequent fibrosis assessment and&#47;or specialist referral&#46; Validated non-invasive measures&#44; such as the Hepamet fibrosis scoring system&#44; are more accurate <a class="elsevierStyleCrossRef" href="#bib0028">&#91;28&#93;</a> but require specialized parameters &#40;i&#46;e&#46;&#44; homeostatic model assessment score&#41; not readily available in resource-limited settings&#46; Evaluating those with type 2 diabetes complications using the FIB-4 score may help primary providers or healthcare systems identify those patients most at risk for liver-related complications from NAFLD and focus resources accordingly &#40;e&#46;g&#46;&#44; sub-specialty consultation&#41;&#46; <a class="elsevierStyleCrossRef" href="#fig0002">Fig&#46; 2</a> illustrates a proposed algorithm for screening high-risk patients with type 2 diabetes in resource-limited settings&#46;</p><elsevierMultimedia ident="fig0002"></elsevierMultimedia><p id="para0019" class="elsevierStylePara elsevierViewall">Although the results are revealing&#44; limitations of this study exist&#46; First off&#44; a more granular alcohol use history was not reliably captured in the record&#46; Although those with known ALD were excluded&#44; individuals with high-risk drinking behaviors may have been inadvertently included in the study population leading to misclassification&#46; Additionally&#44; patients who did not have available FIB-4 labs were not evaluated in this study&#44; which may lead to selection bias&#46; FIB-4 is also less reliable in those above 65 years of age and should be interpreted with caution in this subgroup or be used with different cut-off values&#44; as suggested by McPherson <span class="elsevierStyleItalic">et al</span>&#46; <a class="elsevierStyleCrossRef" href="#bib0029">&#91;29&#93;</a>&#46; Additional factors&#44; such as gamma-glutamyl transferase levels&#44; glycemic&#47;metabolic variability&#44; or the presence of diabetic foot ulcer&#44; are associated with type 2 diabetes&#44; NAFLD&#44; or related conditions but were not captured reliably in our record and may serve as future targets for study&#46; Lastly&#44; the retrospective nature of the study does not permit inquiry into the indication for laboratory testing&#46; We adjusted for measured covariates&#59; however&#44; unmeasured covariates may still exist&#46; Estimating fibrosis levels with the gold standard diagnostic method of liver biopsy is challenging when studying patients in the primary care community&#44; but a preponderance of evidence now suggests FIB-4 as a reliable screening tool&#46;</p></span><span id="sec0007" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">5</span><span class="elsevierStyleSectionTitle" id="cesectitle0013">Conclusions</span><p id="para0020" class="elsevierStylePara elsevierViewall">Despite these limitations&#44; the results from this study support the use of FIB-4 as a straightforward and low-cost method for the triage of diabetic patients at greatest risk for liver-related complications&#46; In settings where evaluation with advanced non-invasive modalities for fibrosis staging and&#47;or hepatology consultation is not available for all patients at risk of chronic liver disease&#44; the FIB-4 score can serve as an effective method for identifying the patients at greatest risk&#46; In conclusion&#44; patients with type 2 diabetes&#44; and particularly those with complications&#44; should have non-invasive liver fibrosis evaluation as a component of their systematic type 2 diabetes screening protocols&#46;</p></span><span id="sec0008" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0014">Funding</span><p id="para0021" class="elsevierStylePara elsevierViewall">HDT is supported by AASLD Transplant Hepatology Award&#46; ZF is supported by the AASLD Foundation&#46; MPC receives research funding from Sonic Incytes&#44; Gilead&#44; and Mallinckrodt&#44; as well as consulting fees from Gilead&#44; Sonic Incytes&#44; Mallinckrodt and Alexion&#46; This work was completed independently of the above funding sources&#46;</p></span><span id="coi0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0015">Declaration of interest</span><p id="para0022" class="elsevierStylePara elsevierViewall">None&#46;</p></span><span id="sec0008a" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0014a">Author contributions</span><p id="para0021a" class="elsevierStylePara elsevierViewall">Hirsh D&#46; Trivedi&#58; Conceptualization&#44; Formal analysis&#44; Data curation&#44; Writing &#8211; review &#38; editing&#46; Qua Tran&#58; Formal analysis&#44; Data curation&#46; Zachary Fricker&#58; Writing &#8211; review &#38; editing&#44; Supervision&#44; Visualization&#46; Michael P&#46; Curry&#58; Supervision&#44; Visualization&#46; Jonathan X&#46; Li&#58; Conceptualization&#44; Supervision&#44; Visualization&#46; Michelle Lai&#58; Conceptualization&#44; Supervision&#44; Visualization&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:11 [
        0 => array:2 [
          "identificador" => "xpalclavsec1637471"
          "titulo" => "Keywords"
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1637472"
          "titulo" => "Abbreviations"
        ]
        2 => array:2 [
          "identificador" => "sec0001"
          "titulo" => "Introduction"
        ]
        3 => array:3 [
          "identificador" => "sec0002"
          "titulo" => "Materials and Methods"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0003"
              "titulo" => "Statistical methods"
            ]
            1 => array:2 [
              "identificador" => "sec0004"
              "titulo" => "Ethical statement"
            ]
          ]
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Results"
        ]
        5 => array:2 [
          "identificador" => "sec0006"
          "titulo" => "Discussion"
        ]
        6 => array:2 [
          "identificador" => "sec0007"
          "titulo" => "Conclusions"
        ]
        7 => array:2 [
          "identificador" => "sec0008"
          "titulo" => "Funding"
        ]
        8 => array:2 [
          "identificador" => "coi0001"
          "titulo" => "Declaration of interest"
        ]
        9 => array:2 [
          "identificador" => "sec0008a"
          "titulo" => "Author contributions"
        ]
        10 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2022-11-10"
    "fechaAceptado" => "2023-01-24"
    "PalabrasClave" => array:1 [
      "en" => array:2 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1637471"
          "palabras" => array:4 [
            0 => "Nonalcoholic fatty liver disease"
            1 => "Type 2 diabetes"
            2 => "Hepatic steatosis"
            3 => "Hepatic fibrosis"
          ]
        ]
        1 => array:4 [
          "clase" => "abr"
          "titulo" => "Abbreviations"
          "identificador" => "xpalclavsec1637472"
          "palabras" => array:21 [
            0 => "ADA"
            1 => "ALD"
            2 => "AST"
            3 => "ALT"
            4 => "BIDMC"
            5 => "CI"
            6 => "FIB-4"
            7 => "HCC"
            8 => "HbA1c"
            9 => "ICD"
            10 => "IRB"
            11 => "INR"
            12 => "IQR"
            13 => "LDL"
            14 => "BMI"
            15 => "LSM"
            16 => "NAFLD"
            17 => "NASH"
            18 => "P"
            19 => "TE"
            20 => "TX"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "en" => array:2 [
        "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0001">Introduction and Objectives</span><p id="spara008" class="elsevierStyleSimplePara elsevierViewall">The association between type 2 diabetes&#44; non-alcoholic fatty liver disease&#44; and liver fibrosis is well established&#44; but it is unknown whether complications of type 2 diabetes influence fibrosis levels&#46; We defined the complications of type 2 diabetes by the presence of diabetic nephropathy&#44; retinopathy&#44; or neuropathy and aimed to evaluate their association with the degree of liver fibrosis measured by the fibrosis-4 &#40;FIB-4&#41; index&#46;</p></span> <span id="abss0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0002">Materials and Methods</span><p id="spara009" class="elsevierStyleSimplePara elsevierViewall">This is a cross-sectional study evaluating the association of type 2 diabetes complications with liver fibrosis&#46; A total of 2389 participants were evaluated from a primary care practice&#46; FIB-4 was evaluated as a continuous and categorical measure using linear and ordinal logistic regression&#46;</p></span> <span id="abss0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0003">Results</span><p id="spara010" class="elsevierStyleSimplePara elsevierViewall">Patients with complications were older&#44; had higher hemoglobin A1c&#44; and a higher median FIB-4 score &#40;1&#46;34 vs&#46; 1&#46;12&#44; P&#60;0&#46;001&#41;&#46; On adjusted analysis&#44; type 2 diabetes complications were associated with higher fibrosis by continuous FIB-4 score &#40;Beta-coefficient&#58; 0&#46;23&#44; 95&#37; confidence interval &#91;CI&#93;&#58; 0&#46;004-1&#46;65&#41; and demonstrated increased odds of fibrosis by categorical FIB-4 score &#40;odds ratio &#91;OR&#93;&#58; 4&#46;48&#44; 95&#37; CI&#58; 1&#46;7-11&#46;8&#44; P&#61;0&#46;003&#41;&#44; independent of hemoglobin A1c level&#46;</p></span> <span id="abss0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0004">Conclusions</span><p id="spara011" class="elsevierStyleSimplePara elsevierViewall">The presence of type 2 diabetes complications is associated with the degree of liver fibrosis&#44; independent of hemoglobin A1c level&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abss0001"
            "titulo" => "Introduction and Objectives"
          ]
          1 => array:2 [
            "identificador" => "abss0002"
            "titulo" => "Materials and Methods"
          ]
          2 => array:2 [
            "identificador" => "abss0003"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abss0004"
            "titulo" => "Conclusions"
          ]
        ]
      ]
    ]
    "multimedia" => array:4 [
      0 => array:8 [
        "identificador" => "fig0001"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1211
            "Ancho" => 1667
            "Tamanyo" => 79678
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0001"
            "detalle" => "Fig "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall">Liver stiffness measurement &#40;LSM&#41; by transient elastography correlates with Fibrosis-4 score categories&#46; FIB-4&#58; fibrosis-4 score&#46; LSM values are reported as median &#40;interquartile range&#41;&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig0002"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1903
            "Ancho" => 1667
            "Tamanyo" => 167294
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0002"
            "detalle" => "Fig "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara002" class="elsevierStyleSimplePara elsevierViewall">A proposed algorithm for non-alcoholic fatty liver disease screening in patients with type 2 diabetes in resource-limited settings&#46; NAFLD&#58; non-alcoholic fatty liver disease&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0001"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0003"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spara004" class="elsevierStyleSimplePara elsevierViewall">SD&#58; standard deviation&#44; IQR&#58; interquartile range&#44; BMI&#58; body-mass index&#44; HbA1c&#58; hemoglobin A1c&#44; ALT&#58; alanine aminotransferase&#44; AST&#58; aspartate aminotransferase&#44; INR&#58; international normalized ratio&#44; LDL&#58; low-density lipoprotein&#46;</p><p id="spara005" class="elsevierStyleSimplePara elsevierViewall">&#40;Normally distributed variables are reported as mean &#40;SD&#41; whereas median &#40;IQR&#41; is reported for variables that are not normally distributed&#46;&#41;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0001"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0002"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">No Complications&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0003"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Complications&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0004"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">P-value&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0005"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Total No&#46;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0006"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">1228&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0007"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">1026&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0008"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0009"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Age &#40;SD&#41;&#44;</span> years&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0010"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">62&#46;7 &#40;13&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0011"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">68 &#40;12&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0012"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0013"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Female&#44;</span> &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0014"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">655 &#40;53&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0015"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">543 &#40;52&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0016"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;84&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0017"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">BMI &#40;SD&#41;&#44;</span> kg&#47;m2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0018"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">32&#46;3 &#40;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0019"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">32&#46;2 &#40;8&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0020"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;84&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0021"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">HbA1c &#40;SD&#41;&#44;</span> &#37; &#91;mmol&#47;mol&#93;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0022"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&#46;3 &#40;1&#46;5&#41; &#91;56 mmol&#47;mol&#93;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0023"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&#46;9 &#40;1&#46;5&#41; &#91;63 mmol&#47;mol&#93;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0024"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;005&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0025"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">ALT level &#40;IQR&#41;&#44;</span> IU&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0026"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">35 &#40;24&#44; 47&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0027"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#46;5 &#40;19&#44; 49&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0028"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;17&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0029"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">AST level &#40;IQR&#41;&#44;</span> IU&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0030"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">27 &#40;19&#44; 34&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0031"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">27&#46;5 &#40;19&#44; 38&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0032"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;61&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0033"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Platelet &#40;IQR&#41;&#44;</span> K&#47;uL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0034"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">243 &#40;201&#44; 308&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0035"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">234 &#40;176&#44; 285&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0036"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;064&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0037"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">INR &#40;SD&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0038"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;1 &#40;0&#46;22&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0039"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;2 &#40;0&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0040"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;078&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0041"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">LDL &#40;SD&#41;&#44;</span> mg&#47;dL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0042"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">95&#46;2 &#40;38&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0043"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">82&#46;2 &#40;32&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0044"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;036&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0045"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Creatinine &#40;IQR&#41;&#44;</span> mg&#47;dL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0046"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;9 &#40;0&#46;7&#44; 1&#46;0&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0047"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;0&#46;8&#44; 1&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0048"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0049"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Any Alcohol Use &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0050"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">35 &#40;2&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0051"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">39 &#40;3&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0052"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;21&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0053"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Tobacco &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0054"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100 &#40;8&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0055"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">109 &#40;10&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0056"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;043&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0057"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Aspirin &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0058"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">196 &#40;16&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0059"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">271 &#40;26&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0060"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0061"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Statin &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0062"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">838 &#40;68&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0063"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">800 &#40;78&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0064"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0065"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Insulin &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0066"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">139 &#40;11&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0067"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">335 &#40;32&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0068"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0069"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">Subspecialty Hepatology Care &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0070"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">202 &#40;16&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0071"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">184 &#40;17&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0072"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;35&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0073"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">FIB-4 &#40;IQR&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0074"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;12 &#40;0&#46;81&#44; 1&#46;58&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0075"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;34 &#40;0&#46;97&#44; 1&#46;90&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0076"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0077"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleBold">FIB4 Stage &#40;&#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0078"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0079"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0080"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0081"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Limited&#58; &#60; 1&#46;45&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0082"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">867 &#40;70&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0083"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">584 &#40;56&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0084"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0085"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Indeterminate&#58; 1&#46;45-3&#46;25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0086"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">323 &#40;26&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0087"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">397 &#40;38&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0088"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0089"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Advanced&#58; &#62; 3&#46;25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0090"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">38 &#40;3&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0091"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="char" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">45 &#40;4&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0092"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab3163374.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara003" class="elsevierStyleSimplePara elsevierViewall">Baseline characteristics of type 2 diabetes study population&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0002"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "alt0004"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spara007" class="elsevierStyleSimplePara elsevierViewall">FIB-4&#58; fibrosis-4 index&#44; CI&#58; confidence interval&#44; HbA1c&#58; hemoglobin A1c&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0093"></a><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Exposure&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><a name="en0094"></a><th class="td-with-role" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t ; entry_with_role_colgroup " colspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Unadjusted</th><a name="en0095"></a><th class="td-with-role" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t ; entry_with_role_colgroup " colspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Model 1<a class="elsevierStyleCrossRef" href="#tb2fn1">&#42;</a></th><a name="en0096"></a><th class="td-with-role" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t ; entry_with_role_colgroup " colspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Model 2<a class="elsevierStyleCrossRef" href="#tb2fn2"><span class="elsevierStyleSup">&#8224;</span></a></th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0097"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowgroup " rowspan="6" align="left" valign="top">Type 2 Diabetes Complications</td><a name="en0098"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_colgroup " colspan="6" align="center" valign="top"><span class="elsevierStyleBold">Continuous FIB-4 Score</span></td></tr><tr title="table-row"><a name="en0100"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">&#946;-coefficient &#40;95&#37; CI&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0101"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">P-value</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0102"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">&#946;-coefficient &#40;95&#37; CI&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0103"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">P-value</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0104"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">&#946;-coefficient &#40;95&#37; CI&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0105"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">P-value</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0107"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">0&#46;23 &#40;0&#46;11 to 0&#46;34&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0108"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0109"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">0&#46;83 &#40;0&#46;004 to 1&#46;65&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0110"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">0&#46;049&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0111"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">0&#46;59 &#40;-0&#46;23 to 1&#46;40&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0112"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">0&#46;16&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0114"></a><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_colgroup " colspan="6" align="center" valign="top"><span class="elsevierStyleBold">Categorical FIB-4 Score</span></td></tr><tr title="table-row"><a name="en0116"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">Odds Ratio &#40;95&#37; CI&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0117"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">P-value</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0118"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">Odds Ratio &#40;95&#37; CI&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0119"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">P-value</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0120"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">Odds Ratio &#40;95&#37; CI&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0121"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top"><span class="elsevierStyleBold">P-value</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><a name="en0123"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">1&#46;79 &#40;1&#46;51 to 2&#46;13&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0124"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0125"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">4&#46;48 &#40;1&#46;69 to 11&#46;84&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0126"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">0&#46;003&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0127"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">3&#46;96 &#40;1&#46;57 to 9&#46;99&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><a name="en0128"></a><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="top">0&#46;004&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab3163373.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tb2fn1"
              "etiqueta" => "&#8270;"
              "nota" => "<p class="elsevierStyleNotepara" id="notep0004">Model 1 adjusts for body-mass index&#44; sex&#44; HbA1c&#44; and any alcohol use&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tb2fn2"
              "etiqueta" => "&#8224;"
              "nota" => "<p class="elsevierStyleNotepara" id="notep0005">Model 2 adjusts for covariates identified using stepwise forward selection&#44; which includes Aspirin use in the linear model and HbA1c in the ordinal logistic model&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spara006" class="elsevierStyleSimplePara elsevierViewall">Association of type 2 diabetes complications with Fibrosis-4 index&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "cebibsec1"
          "bibliografiaReferencia" => array:29 [
            0 => array:3 [
              "identificador" => "bib0001"
              "etiqueta" => "&#91;1&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global burden of NAFLD and NASH&#58; trends&#44; predictions&#44; risk factors and prevention"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Z&#46; Younossi"
                            1 => "Q&#46;M&#46; Anstee"
                            2 => "M&#46; Marietti"
                            3 => "T&#46; Hardy"
                            4 => "L&#46; Henry"
                            5 => "M&#46; Eslam"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrgastro.2017.109"
                      "Revista" => array:7 [
                        "tituloSerie" => "Nat Rev Gastroenterol Hepatol"
                        "fecha" => "2018"
                        "volumen" => "15"
                        "numero" => "1"
                        "paginaInicial" => "11"
                        "paginaFinal" => "20"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28930295"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0002"
              "etiqueta" => "&#91;2&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiology of chronic liver diseases in the USA in the past three decades"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Z&#46;M&#46; Younossi"
                            1 => "M&#46; Stepanova"
                            2 => "Y&#46; Younossi"
                            3 => "P&#46; Golabi"
                            4 => "A&#46; Mishra"
                            5 => "N&#46; Rafiq"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/gutjnl-2019-318813"
                      "Revista" => array:7 [
                        "tituloSerie" => "Gut"
                        "fecha" => "2020"
                        "volumen" => "69"
                        "numero" => "3"
                        "paginaInicial" => "564"
                        "paginaFinal" => "568"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31366455"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0003"
              "etiqueta" => "&#91;3&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence&#44; incidence&#44; and outcomes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Z&#46;M&#46; Younossi"
                            1 => "A&#46;B&#46; Koenig"
                            2 => "D&#46; Abdelatif"
                            3 => "Y&#46; Fazel"
                            4 => "L&#46; Henry"
                            5 => "M&#46; Wymer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.28431"
                      "Revista" => array:7 [
                        "tituloSerie" => "Hepatology &#40;Baltimore&#44; Md&#41;"
                        "fecha" => "2016"
                        "volumen" => "64"
                        "numero" => "1"
                        "paginaInicial" => "73"
                        "paginaFinal" => "84"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26707365"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0004"
              "etiqueta" => "&#91;4&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hepatocellular carcinoma in the absence of cirrhosis in united states veterans is associated with non-alcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Mittal"
                            1 => "H&#46;B&#46; El-Serag"
                            2 => "Y&#46;H&#46; Sada"
                            3 => "F&#46; Kanwal"
                            4 => "Z&#46; Duan"
                            5 => "S&#46; Temple"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.cgh.2015.07.019"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"
                        "fecha" => "2016"
                        "volumen" => "14"
                        "numero" => "1"
                        "paginaInicial" => "124"
                        "paginaFinal" => "131"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "&#91;5&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Severe hepatic steatosis by controlled attenuation parameter predicts quality of life independent of fibrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "H&#46;D&#46; Trivedi"
                            1 => "S&#46; Niezen"
                            2 => "Z&#46;G&#46; Jiang"
                            3 => "E&#46;B&#46; Tapper"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10620-021-07228-3"
                      "Revista" => array:2 [
                        "tituloSerie" => "Dig Dis Sci"
                        "fecha" => "2021"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0006"
              "etiqueta" => "&#91;6&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Non-alcoholic Fatty Liver Disease &#40;NAFLD&#41; is associated with impairment of Health Related Quality of Life &#40;HRQOL&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Golabi"
                            1 => "M&#46; Otgonsuren"
                            2 => "R&#46; Cable"
                            3 => "S&#46; Felix"
                            4 => "A&#46; Koenig"
                            5 => "M&#46; Sayiner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s12955-016-0420-z"
                      "Revista" => array:5 [
                        "tituloSerie" => "Health Qual Life Outcomes"
                        "fecha" => "2016"
                        "volumen" => "14"
                        "paginaInicial" => "18"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26860700"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0007"
              "etiqueta" => "&#91;7&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Healthcare cost and utilization in non-alcoholic fatty liver disease&#58; real-world data from a large U&#46;S&#46; claims database"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46;M&#46; Allen"
                            1 => "H&#46;K&#46; Van Houten"
                            2 => "L&#46;R&#46; Sangaralingham"
                            3 => "J&#46;A&#46; Talwalkar"
                            4 => "RG&#46; McCoy"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.30094"
                      "Revista" => array:7 [
                        "tituloSerie" => "Hepatology &#40;Baltimore&#44; Md&#41;"
                        "fecha" => "2018"
                        "volumen" => "68"
                        "numero" => "6"
                        "paginaInicial" => "2230"
                        "paginaFinal" => "2238"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29774589"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0008"
              "etiqueta" => "&#91;8&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Non-alcoholic fatty liver disease is underrecognized in the primary care setting"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "P&#46; Blais"
                            1 => "N&#46; Husain"
                            2 => "J&#46;R&#46; Kramer"
                            3 => "M&#46; Kowalkowski"
                            4 => "H&#46; El-Serag"
                            5 => "F&#46; Kanwal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ajg.2014.134"
                      "Revista" => array:7 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "2015"
                        "volumen" => "110"
                        "numero" => "1"
                        "paginaInicial" => "10"
                        "paginaFinal" => "14"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24890441"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0009"
              "etiqueta" => "&#91;9&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The impact of non-alcoholic fatty liver disease in primary care&#58; a population health perspective"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Dokmak"
                            1 => "B&#46; Lizaola-Mayo"
                            2 => "H&#46;D&#46; Trivedi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjmed.2020.08.010"
                      "Revista" => array:2 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "2020"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "&#91;10&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Serial transient elastography examinations to monitor patients with type 2 diabetes&#58; a prospective cohort study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46;W&#46; Lee"
                            1 => "G&#46;L&#46; Wong"
                            2 => "R&#46; Kwok"
                            3 => "K&#46;C&#46; Choi"
                            4 => "C&#46;K&#46; Chan"
                            5 => "S&#46;S&#46; Shu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.31142"
                      "Revista" => array:2 [
                        "tituloSerie" => "Hepatology &#40;Baltimore&#44; Md&#41;"
                        "fecha" => "2020"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0011"
              "etiqueta" => "&#91;11&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD&#58; real-world study of 18 million patients in four European cohorts"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Alexander"
                            1 => "A&#46;K&#46; Loomis"
                            2 => "J&#46; van der Lei"
                            3 => "T&#46; Duarte-Salles"
                            4 => "D&#46; Prieto-Alhambra"
                            5 => "D&#46; Ansell"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/s12916-019-1321-x"
                      "Revista" => array:6 [
                        "tituloSerie" => "BMC Med"
                        "fecha" => "2019"
                        "volumen" => "17"
                        "numero" => "1"
                        "paginaInicial" => "95"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31104631"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0012"
              "etiqueta" => "&#91;12&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetes is associated with increased risk of hepatocellular carcinoma in cirrhosis patients with non-alcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;D&#46; Yang"
                            1 => "F&#46; Ahmed"
                            2 => "K&#46;C&#46; Mara"
                            3 => "B&#46;D&#46; Addissie"
                            4 => "A&#46;M&#46; Allen"
                            5 => "G&#46;J&#46; Gores"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.30858"
                      "Revista" => array:2 [
                        "tituloSerie" => "Hepatology &#40;Baltimore&#44; Md&#41;"
                        "fecha" => "2019"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0013"
              "etiqueta" => "&#91;13&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46;D&#46; Trivedi"
                            1 => "J&#46; Suri"
                            2 => "D&#46; Oh"
                            3 => "J&#46; Schwartz"
                            4 => "D&#46; Goyes"
                            5 => "R&#46; Idriss"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.aohep.2021.100336"
                      "Revista" => array:3 [
                        "tituloSerie" => "Ann Hepatol"
                        "fecha" => "2021"
                        "volumen" => "24"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0014"
              "etiqueta" => "&#91;14&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Shedding light on non-alcoholic fatty liver disease&#58; pathogenesis&#44; molecular mechanisms&#44; models&#44; and emerging therapeutics"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46; Khairnar"
                            1 => "M&#46;A&#46; Islam"
                            2 => "J&#46; Fleishman"
                            3 => "S&#46; Kumar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.lfs.2022.121185"
                      "Revista" => array:3 [
                        "tituloSerie" => "Life Sci"
                        "fecha" => "2023"
                        "volumen" => "312"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "&#91;15&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Differential associations of circulating microRNAs with pathogenic factors in NAFLD"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Ezaz"
                            1 => "H&#46;D&#46; Trivedi"
                            2 => "M&#46;A&#46; Connelly"
                            3 => "C&#46; Filozof"
                            4 => "K&#46; Howard"
                            5 => "M&#46; LP"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep4.1501"
                      "Revista" => array:7 [
                        "tituloSerie" => "Hepatol Commun"
                        "fecha" => "2020"
                        "volumen" => "4"
                        "numero" => "5"
                        "paginaInicial" => "670"
                        "paginaFinal" => "680"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32363318"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0016"
              "etiqueta" => "&#91;16&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Glycemic variability is an independent predictive factor for development of hepatic fibrosis in non-alcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Hashiba"
                            1 => "M&#46; Ono"
                            2 => "H&#46; Hyogo"
                            3 => "Y&#46; Ikeda"
                            4 => "K&#46; Masuda"
                            5 => "R&#46; Yoshioka"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0076161"
                      "Revista" => array:6 [
                        "tituloSerie" => "PLOS One"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "numero" => "11"
                        "paginaInicial" => "e76161"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24223115"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0017"
              "etiqueta" => "&#91;17&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Improving care and promoting health in populations&#58; standards of medical care in diabetes-2020"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "Association AD&#46; 1"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2337/dc20-S001"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2020"
                        "volumen" => "43"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "S7"
                        "paginaFinal" => "s13"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31862744"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0018"
              "etiqueta" => "&#91;18&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Elevated glycated hemoglobin is associated with liver fibrosis&#44; as assessed by elastography&#44; in a population-based study of Mexican Americans"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46;P&#46; Watt"
                            1 => "I&#46; De La Cerda"
                            2 => "J&#46;J&#46; Pan"
                            3 => "M&#46;B&#46; Fallon"
                            4 => "L&#46; Beretta"
                            5 => "R&#46; Loomba"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep4.1603"
                      "Revista" => array:7 [
                        "tituloSerie" => "Hepatol Commun"
                        "fecha" => "2020"
                        "volumen" => "4"
                        "numero" => "12"
                        "paginaInicial" => "1793"
                        "paginaFinal" => "1801"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33305150"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0019"
              "etiqueta" => "&#91;19&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibrosis-4 index as an independent predictor of mortality and liver-related outcomes in NAFLD"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Vieira Barbosa"
                            1 => "S&#46; Milligan"
                            2 => "A&#46; Frick"
                            3 => "J&#46; Broestl"
                            4 => "Z&#46; Younossi"
                            5 => "N&#46;H&#46; Afdhal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep4.1841"
                      "Revista" => array:2 [
                        "tituloSerie" => "Hepatol Commun"
                        "fecha" => "2021"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "&#91;20&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fibrosis-4 index can independently predict major adverse cardiovascular events in nonalcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Vieira Barbosa"
                            1 => "S&#46; Milligan"
                            2 => "A&#46; Frick"
                            3 => "J&#46; Broestl"
                            4 => "Z&#46; Younossi"
                            5 => "N&#46; Afdhal"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.14309/ajg.0000000000001606"
                      "Revista" => array:2 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "2022"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0021"
              "etiqueta" => "&#91;21&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Accuracy of non-invasive scoring systems in assessing liver fibrosis in patients with non-alcoholic fatty liver disease&#58; a systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Han"
                            1 => "M&#46; Choi"
                            2 => "B&#46; Lee"
                            3 => "H&#46;W&#46; Lee"
                            4 => "S&#46;H&#46; Kang"
                            5 => "Y&#46; Cho"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5009/gnl210391"
                      "Revista" => array:2 [
                        "tituloSerie" => "Gut Liver"
                        "fecha" => "2022"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0022"
              "etiqueta" => "&#91;22&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD&#58; an individual patient data meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46;E&#46; M&#243;zes"
                            1 => "J&#46;A&#46; Lee"
                            2 => "E&#46;A&#46; Selvaraj"
                            3 => "A&#46;N&#46;A&#46; Jayaswal"
                            4 => "M&#46; Trauner"
                            5 => "J&#46; Boursier"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/gutjnl-2021-324243"
                      "Revista" => array:2 [
                        "tituloSerie" => "Gut"
                        "fecha" => "2021"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0023"
              "etiqueta" => "&#91;23&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact of implementing a &#8220;FIB-4 first&#8221; strategy on a pathway for patients with NAFLD referred from primary care"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "T&#46; Davyduke"
                            1 => "P&#46; Tandon"
                            2 => "M&#46; Al-Karaghouli"
                            3 => "J&#46;G&#46; Abraldes"
                            4 => "MM&#46; Ma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep4.1411"
                      "Revista" => array:7 [
                        "tituloSerie" => "Hepatol Commun"
                        "fecha" => "2019"
                        "volumen" => "3"
                        "numero" => "10"
                        "paginaInicial" => "1322"
                        "paginaFinal" => "1333"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31592044"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0024"
              "etiqueta" => "&#91;24&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Srivastava"
                            1 => "R&#46; Gailer"
                            2 => "S&#46; Tanwar"
                            3 => "P&#46; Trembling"
                            4 => "J&#46; Parkes"
                            5 => "A&#46; Rodger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jhep.2019.03.033"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "2019"
                        "volumen" => "71"
                        "numero" => "2"
                        "paginaInicial" => "371"
                        "paginaFinal" => "378"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30965069"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "&#91;25&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An algorithmic approach to NAFLD screening&#58; from PCP to specialist"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "H&#46;D&#46; Trivedi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.14309/crj.0000000000000473"
                      "Revista" => array:6 [
                        "tituloSerie" => "ACG Case Rep J"
                        "fecha" => "2020"
                        "volumen" => "7"
                        "numero" => "11"
                        "paginaInicial" => "e00473"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33195729"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0026"
              "etiqueta" => "&#91;26&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "FIB-4&#58; an inexpensive and accurate marker of fibrosis in HCV infection&#46; comparison with liver biopsy and fibrotest"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Vallet-Pichard"
                            1 => "V&#46; Mallet"
                            2 => "B&#46; Nalpas"
                            3 => "V&#46; Verkarre"
                            4 => "A&#46; Nalpas"
                            5 => "V&#46; Dhalluin-Venier"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.21669"
                      "Revista" => array:7 [
                        "tituloSerie" => "Hepatology &#40;Baltimore&#44; Md&#41;"
                        "fecha" => "2007"
                        "volumen" => "46"
                        "numero" => "1"
                        "paginaInicial" => "32"
                        "paginaFinal" => "36"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17567829"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0027"
              "etiqueta" => "&#91;27&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact of type 2 diabetes on the accuracy of noninvasive tests of liver fibrosis with resulting clinical implications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Boursier"
                            1 => "C&#46;M&#46; Canivet"
                            2 => "C&#46; Costentin"
                            3 => "A&#46; Lannes"
                            4 => "A&#46; Delamarre"
                            5 => "N&#46; Sturm"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.cgh.2022.02.059"
                      "Revista" => array:2 [
                        "tituloSerie" => "Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"
                        "fecha" => "2022"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0028"
              "etiqueta" => "&#91;28&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Development and validation of hepamet fibrosis scoring system-a simple&#44; noninvasive test to identify patients with non-alcoholic fatty liver disease with advanced fibrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Ampuero"
                            1 => "R&#46; Pais"
                            2 => "R&#46; Aller"
                            3 => "R&#46; Gallego-Dur&#225;n"
                            4 => "J&#46; Crespo"
                            5 => "C&#46; Garc&#237;a-Monz&#243;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.cgh.2019.05.051"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"
                        "fecha" => "2020"
                        "volumen" => "18"
                        "numero" => "1"
                        "paginaInicial" => "216"
                        "paginaFinal" => "225"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0029"
              "etiqueta" => "&#91;29&#93;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; McPherson"
                            1 => "T&#46; Hardy"
                            2 => "J&#46;F&#46; Dufour"
                            3 => "S&#46; Petta"
                            4 => "M&#46; Romero-Gomez"
                            5 => "M&#46; Allison"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ajg.2016.453"
                      "Revista" => array:7 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "2017"
                        "volumen" => "112"
                        "numero" => "5"
                        "paginaInicial" => "740"
                        "paginaFinal" => "751"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27725647"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/16652681/0000002800000003/v2_202305031521/S1665268123001916/v2_202305031521/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "78265"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original Articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/16652681/0000002800000003/v2_202305031521/S1665268123001916/v2_202305031521/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123001916?idApp=UINPBA00004N"
]

Article information

ISSN: 16652681
Original language: English

DOI:10.1016/j.aohep.2023.101087

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	5	0	5
2024 October	52	3	55
2024 September	51	9	60
2024 August	46	11	57
2024 July	43	9	52
2024 June	42	6	48
2024 May	57	5	62
2024 April	46	4	50
2024 March	50	7	57
2024 February	46	14	60
2024 January	37	9	46
2023 December	18	5	23
2023 November	13	7	20
2023 October	22	32	54
2023 September	13	11	24
2023 August	6	4	10
2023 July	4	0	4
2023 June	12	2	14
2023 May	16	6	22
2023 April	39	6	45
2023 March	9	2	11

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter